Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

RIT1 oncoproteins escape LZTR1-mediated proteolysis.

Castel P, Cheng A, Cuevas-Navarro A, Everman DB, Papageorge AG, Simanshu DK, Tankka A, Galeas J, Urisman A, McCormick F.

Science. 2019 Mar 15;363(6432):1226-1230. doi: 10.1126/science.aav1444.

PMID:
30872527
2.

Demonstration of universal parametric entangling gates on a multi-qubit lattice.

Reagor M, Osborn CB, Tezak N, Staley A, Prawiroatmodjo G, Scheer M, Alidoust N, Sete EA, Didier N, da Silva MP, Acala E, Angeles J, Bestwick A, Block M, Bloom B, Bradley A, Bui C, Caldwell S, Capelluto L, Chilcott R, Cordova J, Crossman G, Curtis M, Deshpande S, El Bouayadi T, Girshovich D, Hong S, Hudson A, Karalekas P, Kuang K, Lenihan M, Manenti R, Manning T, Marshall J, Mohan Y, O'Brien W, Otterbach J, Papageorge A, Paquette JP, Pelstring M, Polloreno A, Rawat V, Ryan CA, Renzas R, Rubin N, Russel D, Rust M, Scarabelli D, Selvanayagam M, Sinclair R, Smith R, Suska M, To TW, Vahidpour M, Vodrahalli N, Whyland T, Yadav K, Zeng W, Rigetti CT.

Sci Adv. 2018 Feb 2;4(2):eaao3603. doi: 10.1126/sciadv.aao3603. eCollection 2018 Feb.

3.

Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.

Tripathi BK, Grant T, Qian X, Zhou M, Mertins P, Wang D, Papageorge AG, Tarasov SG, Hunter KW, Carr SA, Lowy DR.

J Cell Biol. 2017 Dec 4;216(12):4255-4270. doi: 10.1083/jcb.201703105. Epub 2017 Nov 7.

4.

Supermode-density-wave-polariton condensation with a Bose-Einstein condensate in a multimode cavity.

Kollár AJ, Papageorge AT, Vaidya VD, Guo Y, Keeling J, Lev BL.

Nat Commun. 2017 Feb 17;8:14386. doi: 10.1038/ncomms14386.

5.

Coupling to modes of a near-confocal optical resonator using a digital light modulator.

Papageorge AT, Kollár AJ, Lev BL.

Opt Express. 2016 May 30;24(11):11447-57. doi: 10.1364/OE.24.011447.

PMID:
27410072
6.

CDK5 is a major regulator of the tumor suppressor DLC1.

Tripathi BK, Qian X, Mertins P, Wang D, Papageorge AG, Carr SA, Lowy DR.

J Cell Biol. 2014 Dec 8;207(5):627-42. doi: 10.1083/jcb.201405105. Epub 2014 Dec 1.

7.

Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells.

Du X, Qian X, Papageorge A, Schetter AJ, Vass WC, Liu X, Braverman R, Robles AI, Lowy DR.

Cancer Res. 2012 Sep 1;72(17):4405-16. doi: 10.1158/0008-5472.CAN-12-0777. Epub 2012 Jun 12.

8.

Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).

Li G, Du X, Vass WC, Papageorge AG, Lowy DR, Qian X.

Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17129-34. doi: 10.1073/pnas.1112122108. Epub 2011 Oct 3.

9.

E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases.

Asnaghi L, Vass WC, Quadri R, Day PM, Qian X, Braverman R, Papageorge AG, Lowy DR.

Oncogene. 2010 May 13;29(19):2760-71. doi: 10.1038/onc.2010.39. Epub 2010 Mar 15.

10.

The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis.

Qian X, Li G, Vass WC, Papageorge A, Walker RC, Asnaghi L, Steinbach PJ, Tosato G, Hunter K, Lowy DR.

Cancer Cell. 2009 Sep 8;16(3):246-58. doi: 10.1016/j.ccr.2009.07.031.

11.

Evolutionary comparison of ribosomal operon antitermination function.

Arnvig KB, Zeng S, Quan S, Papageorge A, Zhang N, Villapakkam AC, Squires CL.

J Bacteriol. 2008 Nov;190(21):7251-7. doi: 10.1128/JB.00760-08. Epub 2008 Aug 29.

12.

Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis.

Crawford NP, Qian X, Ziogas A, Papageorge AG, Boersma BJ, Walker RC, Lukes L, Rowe WL, Zhang J, Ambs S, Lowy DR, Anton-Culver H, Hunter KW.

PLoS Genet. 2007 Nov;3(11):e214. Epub 2007 Oct 16.

13.

Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.

Qian X, Li G, Asmussen HK, Asnaghi L, Vass WC, Braverman R, Yamada KM, Popescu NC, Papageorge AG, Lowy DR.

Proc Natl Acad Sci U S A. 2007 May 22;104(21):9012-7. Epub 2007 May 15.

14.

Transforming growth factor beta regulates the expression of the M2 muscarinic receptor in atrial myocytes via an effect on RhoA and p190RhoGAP.

Park HJ, Ward SM, Desgrosellier JS, Georgescu SP, Papageorge AG, Zhuang X, Barnett JV, Galper JB.

J Biol Chem. 2006 Jul 21;281(29):19995-20002. Epub 2006 May 16.

15.

TGFbeta regulates the expression of G alpha(i2) via an effect on the localization of ras.

Ward SM, Gadbut AP, Tang D, Papageorge AG, Wu L, Li G, Barnett JV, Galper JB.

J Mol Cell Cardiol. 2002 Sep;34(9):1217-26.

PMID:
12392895
16.

The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties.

Qian X, Esteban L, Vass WC, Upadhyaya C, Papageorge AG, Yienger K, Ward JM, Lowy DR, Santos E.

EMBO J. 2000 Feb 15;19(4):642-54.

17.

Bilateral simultaneous orbital decompression for Graves' orbitopathy with a combined endoscopic and Caldwell-Luc approach.

Rizk SS, Papageorge A, Liberatore LA, Sacks EH.

Otolaryngol Head Neck Surg. 2000 Feb;122(2):216-21.

PMID:
10652393
18.

Endonasal laser-assisted dacryocystorhinostomy.

Szubin L, Papageorge A, Sacks E.

Am J Rhinol. 1999 Sep-Oct;13(5):371-4.

PMID:
10582115
19.

Ras-specific exchange factor GRF: oligomerization through its Dbl homology domain and calcium-dependent activation of Raf.

Anborgh PH, Qian X, Papageorge AG, Vass WC, DeClue JE, Lowy DR.

Mol Cell Biol. 1999 Jul;19(7):4611-22.

21.

N terminus of Sos1 Ras exchange factor: critical roles for the Dbl and pleckstrin homology domains.

Qian X, Vass WC, Papageorge AG, Anborgh PH, Lowy DR.

Mol Cell Biol. 1998 Feb;18(2):771-8.

22.
23.

Leiomyoma of the maxillary sinus: a diagnostic dilemma.

LaBruna A, Reagan B, Papageorge A.

Otolaryngol Head Neck Surg. 1995 Apr;112(4):595-8. Review. No abstract available.

PMID:
7700669
24.

Regulated and constitutive activity by CDC25Mm (GRF), a Ras-specific exchange factor.

Cen H, Papageorge AG, Vass WC, Zhang KE, Lowy DR.

Mol Cell Biol. 1993 Dec;13(12):7718-24.

25.

Cell transformation by ras and regulation of its protein product.

Lowy DR, Johnson MR, DeClue JE, Cen H, Zhang K, Papageorge AG, Vass WC, Willumsen BM, Valentine MB, Look AT.

Ciba Found Symp. 1993;176:67-80; discussion 80-4. Review.

PMID:
8299427
27.

Mechanistic aspects of signaling through Ras in NIH 3T3 cells.

Zhang K, Papageorge AG, Lowy DR.

Science. 1992 Jul 31;257(5070):671-4.

PMID:
1496380
28.

Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.

DeClue JE, Papageorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC, Lowy DR.

Cell. 1992 Apr 17;69(2):265-73.

PMID:
1568246
29.

Heterogeneous amino acids in Ras and Rap1A specifying sensitivity to GAP proteins.

Zhang K, Papageorge AG, Martin P, Vass WC, Olah Z, Polakis PG, McCormick F, Lowy DR.

Science. 1991 Dec 13;254(5038):1630-4.

PMID:
1749934
30.

The bovine papillomavirus E5 oncogene can cooperate with ras: identification of p21 amino acids critical for transformation by c-rasH but not v-rasH.

Willumsen BM, Vass WC, Velu TJ, Papageorge AG, Schiller JT, Lowy DR.

Mol Cell Biol. 1991 Dec;11(12):6026-33.

31.

A ras effector domain mutant which is temperature sensitive for cellular transformation: interactions with GTPase-activating protein and NF-1.

DeClue JE, Stone JC, Blanchard RA, Papageorge AG, Martin P, Zhang K, Lowy DR.

Mol Cell Biol. 1991 Jun;11(6):3132-8.

32.

Tumorigenic transformation of NIH 3T3 cells by the autocrine synthesis of transforming growth factor alpha.

Ju WD, Velu TJ, Vass WC, Papageorge AG, Lowy DR.

New Biol. 1991 Apr;3(4):380-8.

PMID:
2065023
33.

Inhibition of cell growth by lovastatin is independent of ras function.

DeClue JE, Vass WC, Papageorge AG, Lowy DR, Willumsen BM.

Cancer Res. 1991 Jan 15;51(2):712-7.

34.

Early enhancement of calcium currents by H-ras oncoproteins injected into Hermissenda neurons.

Collin C, Papageorge AG, Lowy DR, Alkon DL.

Science. 1990 Dec 21;250(4988):1743-5.

PMID:
2176747
35.

Early regulation of membrane excitability by ras oncogene proteins.

Collin C, Papageorge AG, Sakakibara M, Huddie PL, Lowy DR, Alkon DL.

Biophys J. 1990 Sep;58(3):785-90.

36.

Suppression of c-ras transformation by GTPase-activating protein.

Zhang K, DeClue JE, Vass WC, Papageorge AG, McCormick F, Lowy DR.

Nature. 1990 Aug 23;346(6286):754-6.

PMID:
2201922
37.

Identification of small clusters of divergent amino acids that mediate the opposing effects of ras and Krev-1.

Zhang K, Noda M, Vass WC, Papageorge AG, Lowy DR.

Science. 1990 Jul 13;249(4965):162-5.

PMID:
2115210
38.

Growth properties and tumorigenesis of MCF-7 cells transfected with isogenic mutants of rasH.

Sommers CL, Papageorge A, Wilding G, Gelmann EP.

Cancer Res. 1990 Jan 1;50(1):67-71.

PMID:
2403419
39.

Mutational analysis of a ras catalytic domain.

Willumsen BM, Papageorge AG, Kung HF, Bekesi E, Robins T, Johnsen M, Vass WC, Lowy DR.

Mol Cell Biol. 1986 Jul;6(7):2646-54.

40.

A transforming ras gene can provide an essential function ordinarily supplied by an endogenous ras gene.

Papageorge AG, Willumsen BM, Johnsen M, Kung HF, Stacey DW, Vass WC, Lowy DR.

Mol Cell Biol. 1986 May;6(5):1843-6.

41.

Transforming p21 ras protein: flexibility in the major variable region linking the catalytic and membrane-anchoring domains.

Willumsen BM, Papageorge AG, Hubbert N, Bekesi E, Kung HF, Lowy DR.

EMBO J. 1985 Nov;4(11):2893-6.

42.

Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity.

Kasid A, Lippman ME, Papageorge AG, Lowy DR, Gelmann EP.

Science. 1985 May 10;228(4700):725-8.

PMID:
4039465
43.
44.

The p21 ras C-terminus is required for transformation and membrane association.

Willumsen BM, Christensen A, Hubbert NL, Papageorge AG, Lowy DR.

Nature. 1984 Aug 16-22;310(5978):583-6.

PMID:
6087162
45.

Saccharomyces cerevisiae synthesizes proteins related to the p21 gene product of ras genes found in mammals.

Papageorge AG, Defeo-Jones D, Robinson P, Temeles G, Scolnick EM.

Mol Cell Biol. 1984 Jan;4(1):23-9.

46.

Expression of endogenous p21 ras genes.

Ellis RW, DeFeo D, Papageorge A, Scolnick EM.

Prog Clin Biol Res. 1983;119:67-77. No abstract available.

PMID:
6889382
47.

Mechanism of activation of a human oncogene.

Tabin CJ, Bradley SM, Bargmann CI, Weinberg RA, Papageorge AG, Scolnick EM, Dhar R, Lowy DR, Chang EH.

Nature. 1982 Nov 11;300(5888):143-9.

PMID:
6290897
48.
49.

Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus.

Shih TY, Papageorge AG, Stokes PE, Weeks MO, Scolnick EM.

Nature. 1980 Oct 23;287(5784):686-91.

PMID:
6253810
50.

Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses.

Scolnick EM, Papageorge AG, Shih TY.

Proc Natl Acad Sci U S A. 1979 Oct;76(10):5355-9.

Supplemental Content

Loading ...
Support Center